Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM.

J Hepatol. 2011 Feb;54(2):209-18. doi: 10.1016/j.jhep.2010.07.009. Epub 2010 Sep 6.

PMID:
21095036
2.

Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.

Zhao PW, Jia FY, Shan YX, Ji HF, Feng JY, Niu JQ, Ayana DA, Jiang YF.

Clin Exp Pharmacol Physiol. 2013 Mar;40(3):190-6. doi: 10.1111/1440-1681.12048.

PMID:
23278368
3.

Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.

Li F, Wei H, Wei H, Gao Y, Xu L, Yin W, Sun R, Tian Z.

Gastroenterology. 2013 Feb;144(2):392-401. doi: 10.1053/j.gastro.2012.10.039. Epub 2012 Oct 26.

PMID:
23103614
4.

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S, Mondelli MU.

Gastroenterology. 2009 Sep;137(3):1151-60, 1160.e1-7. doi: 10.1053/j.gastro.2009.05.047. Epub 2009 May 24.

PMID:
19470388
5.

Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.

Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, Musset L, Debré P, Amoura Z, Vieillard V.

Arthritis Rheum. 2011 Jun;63(6):1698-706. doi: 10.1002/art.30313.

6.

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thélu MA, Sturm N, Dariz A, Guillermet C, Pernollet M, Zarski JP, Marche PN, Leroy V, Jouvin-Marche E.

J Hepatol. 2009 Sep;51(3):458-67. doi: 10.1016/j.jhep.2009.05.030. Epub 2009 Jun 25.

7.

Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.

Jia M, Li D, He X, Zhao Y, Peng H, Ma P, Hong K, Liang H, Shao Y.

Clin Exp Immunol. 2013 Jan;171(1):107-16. doi: 10.1111/j.1365-2249.2012.04672.x.

8.

Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.

Miyagi T, Shimizu S, Tatsumi T, Nishio K, Hiramatsu N, Kanto T, Hayashi N, Takehara T.

J Gastroenterol. 2011 Aug;46(8):1020-30. doi: 10.1007/s00535-011-0408-8. Epub 2011 May 11.

PMID:
21559771
9.

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.

Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG.

Gut. 2008 Aug;57(8):1121-8. doi: 10.1136/gut.2007.130963. Epub 2008 Mar 27.

PMID:
18372499
10.

CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.

Rutjens E, Mazza S, Biassoni R, Koopman G, Ugolotti E, Fogli M, Dubbes R, Costa P, Mingari MC, Greenwood EJ, Moretta L, De Maria A, Heeney JL.

Eur J Immunol. 2010 May;40(5):1440-50. doi: 10.1002/eji.200940062. Erratum in: Eur J Immunol. 2010 Jun;40(6):1819. DeMaria, Andrea [corrected to De Maria, Andrea].

11.

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C.

Gut. 2009 Jul;58(7):974-82. doi: 10.1136/gut.2008.163600. Epub 2009 Feb 6.

PMID:
19201769
12.

Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.

Conroy MJ, Mac Nicholas R, Grealy R, Taylor M, Otegbayo JA, O'Dea S, Mulcahy F, Ryan T, Norris S, Doherty DG.

J Viral Hepat. 2015 Mar;22(3):335-45. doi: 10.1111/jvh.12299. Epub 2014 Sep 3.

PMID:
25186004
13.

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Yoon JC, Lim JB, Park JH, Lee JM.

J Virol. 2011 Dec;85(23):12557-69. doi: 10.1128/JVI.00838-11. Epub 2011 Sep 21.

14.

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

Nattermann J, Feldmann G, Ahlenstiel G, Langhans B, Sauerbruch T, Spengler U.

Gut. 2006 Jun;55(6):869-77. Epub 2005 Dec 1.

15.

Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.

Zhang Y, Zhao A, Wang X, Shi G, Jin H, Lin Q.

Fertil Steril. 2008 Nov;90(5):1931-7. Epub 2007 Nov 26.

PMID:
18023431
16.

Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.

Suttmann H, Jacobsen M, Reiss K, Jocham D, Böhle A, Brandau S.

J Urol. 2004 Oct;172(4 Pt 1):1490-5.

PMID:
15371877
17.

Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection.

Tjwa ET, van Oord GW, Biesta PJ, Boonstra A, Janssen HL, Woltman AM.

J Virol. 2012 Apr;86(8):4102-9. doi: 10.1128/JVI.07000-11. Epub 2012 Feb 8.

18.

Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells.

Shi CC, Tjwa ET, Biesta PJ, Boonstra A, Xie Q, Janssen HL, Woltman AM.

J Viral Hepat. 2012 Feb;19(2):e26-33. doi: 10.1111/j.1365-2893.2011.01496.x. Epub 2011 Aug 31.

PMID:
22239523
19.

Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.

Israeli E, Safadi R, Melhem A, Pappo O, Shibolet O, Klein A, Hemed N, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.

Liver Int. 2004 Aug;24(4):295-307.

PMID:
15287852
20.

Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.

Ghosh S, Nandi M, Pal S, Mukhopadhyay D, Chakraborty BC, Khatun M, Bhowmick D, Mondal RK, Das S, Das K, Ghosh R, Banerjee S, Santra A, Chatterjee M, Chowdhury A, Datta S.

Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.

Supplemental Content

Support Center